Epilepsy Diagnosis & Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: E8F09A1C7021EN
Market Monitor Global

Abstracts

Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.

This report contains market size and forecasts of Epilepsy Diagnosis & Treatment in Global, including the following market information:

Global Epilepsy Diagnosis & Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Epilepsy Diagnosis & Treatment market was valued at 8003.9 million in 2021 and is projected to reach US$ 20520 million by 2028, at a CAGR of 14.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnosis (Neurological Exam, Blood Test, Imaging) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Epilepsy Diagnosis & Treatment include Pfizer, Johnson & Johnson, UCB Pharma, Abbott, GlaxoSmithKline, Novartis, Sanofi, Takeda and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epilepsy Diagnosis & Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epilepsy Diagnosis & Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Epilepsy Diagnosis & Treatment Market Segment Percentages, by Type, 2021 (%)

• Diagnosis (Neurological Exam, Blood Test, Imaging)
• Treatment (Medication, Surgery)

Global Epilepsy Diagnosis & Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Epilepsy Diagnosis & Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Epilepsy Diagnosis & Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Epilepsy Diagnosis & Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Epilepsy Diagnosis & Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Epilepsy Diagnosis & Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Johnson & Johnson
• UCB Pharma
• Abbott
• GlaxoSmithKline
• Novartis
• Sanofi
• Takeda
• Medtronic
• Natus Medical
• Siemens

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Epilepsy Diagnosis & Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Epilepsy Diagnosis & Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPILEPSY DIAGNOSIS & TREATMENT OVERALL MARKET SIZE

2.1 Global Epilepsy Diagnosis & Treatment Market Size: 2021 VS 2028
2.2 Global Epilepsy Diagnosis & Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Epilepsy Diagnosis & Treatment Players in Global Market
3.2 Top Global Epilepsy Diagnosis & Treatment Companies Ranked by Revenue
3.3 Global Epilepsy Diagnosis & Treatment Revenue by Companies
3.4 Top 3 and Top 5 Epilepsy Diagnosis & Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epilepsy Diagnosis & Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epilepsy Diagnosis & Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Epilepsy Diagnosis & Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Epilepsy Diagnosis & Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Epilepsy Diagnosis & Treatment Market Size Markets, 2021 & 2028
  4.1.2 Diagnosis (Neurological Exam, Blood Test, Imaging)
  4.1.3 Treatment (Medication, Surgery)
4.2 By Type - Global Epilepsy Diagnosis & Treatment Revenue & Forecasts
  4.2.1 By Type - Global Epilepsy Diagnosis & Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Epilepsy Diagnosis & Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Epilepsy Diagnosis & Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Epilepsy Diagnosis & Treatment Revenue & Forecasts
  5.2.1 By Application - Global Epilepsy Diagnosis & Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Epilepsy Diagnosis & Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Epilepsy Diagnosis & Treatment Market Size, 2021 & 2028
6.2 By Region - Global Epilepsy Diagnosis & Treatment Revenue & Forecasts
  6.2.1 By Region - Global Epilepsy Diagnosis & Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Epilepsy Diagnosis & Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Epilepsy Diagnosis & Treatment Revenue, 2017-2028
  6.3.2 US Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.3.3 Canada Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.3.4 Mexico Epilepsy Diagnosis & Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Epilepsy Diagnosis & Treatment Revenue, 2017-2028
  6.4.2 Germany Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.4.3 France Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.4.4 U.K. Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.4.5 Italy Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.4.6 Russia Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.4.8 Benelux Epilepsy Diagnosis & Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Epilepsy Diagnosis & Treatment Revenue, 2017-2028
  6.5.2 China Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.5.3 Japan Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.5.4 South Korea Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.5.6 India Epilepsy Diagnosis & Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Epilepsy Diagnosis & Treatment Revenue, 2017-2028
  6.6.2 Brazil Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.6.3 Argentina Epilepsy Diagnosis & Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Epilepsy Diagnosis & Treatment Revenue, 2017-2028
  6.7.2 Turkey Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.7.3 Israel Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Epilepsy Diagnosis & Treatment Market Size, 2017-2028
  6.7.5 UAE Epilepsy Diagnosis & Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Epilepsy Diagnosis & Treatment Major Product Offerings
  7.1.4 Pfizer Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Major Product Offerings
  7.2.4 Johnson & Johnson Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 UCB Pharma
  7.3.1 UCB Pharma Corporate Summary
  7.3.2 UCB Pharma Business Overview
  7.3.3 UCB Pharma Epilepsy Diagnosis & Treatment Major Product Offerings
  7.3.4 UCB Pharma Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.3.5 UCB Pharma Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Epilepsy Diagnosis & Treatment Major Product Offerings
  7.4.4 Abbott Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.4.5 Abbott Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Major Product Offerings
  7.5.4 GlaxoSmithKline Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Epilepsy Diagnosis & Treatment Major Product Offerings
  7.6.4 Novartis Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Epilepsy Diagnosis & Treatment Major Product Offerings
  7.7.4 Sanofi Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.7.5 Sanofi Key News
7.8 Takeda
  7.8.1 Takeda Corporate Summary
  7.8.2 Takeda Business Overview
  7.8.3 Takeda Epilepsy Diagnosis & Treatment Major Product Offerings
  7.8.4 Takeda Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.8.5 Takeda Key News
7.9 Medtronic
  7.9.1 Medtronic Corporate Summary
  7.9.2 Medtronic Business Overview
  7.9.3 Medtronic Epilepsy Diagnosis & Treatment Major Product Offerings
  7.9.4 Medtronic Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.9.5 Medtronic Key News
7.10 Natus Medical
  7.10.1 Natus Medical Corporate Summary
  7.10.2 Natus Medical Business Overview
  7.10.3 Natus Medical Epilepsy Diagnosis & Treatment Major Product Offerings
  7.10.4 Natus Medical Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.10.5 Natus Medical Key News
7.11 Siemens
  7.11.1 Siemens Corporate Summary
  7.11.2 Siemens Business Overview
  7.11.3 Siemens Epilepsy Diagnosis & Treatment Major Product Offerings
  7.11.4 Siemens Epilepsy Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.11.5 Siemens Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Epilepsy Diagnosis & Treatment Market Opportunities & Trends in Global Market
Table 2. Epilepsy Diagnosis & Treatment Market Drivers in Global Market
Table 3. Epilepsy Diagnosis & Treatment Market Restraints in Global Market
Table 4. Key Players of Epilepsy Diagnosis & Treatment in Global Market
Table 5. Top Epilepsy Diagnosis & Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epilepsy Diagnosis & Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epilepsy Diagnosis & Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epilepsy Diagnosis & Treatment Product Type
Table 9. List of Global Tier 1 Epilepsy Diagnosis & Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epilepsy Diagnosis & Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epilepsy Diagnosis & Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epilepsy Diagnosis & Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epilepsy Diagnosis & Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epilepsy Diagnosis & Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epilepsy Diagnosis & Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epilepsy Diagnosis & Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Epilepsy Diagnosis & Treatment Product Offerings
Table 32. Pfizer Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Epilepsy Diagnosis & Treatment Product Offerings
Table 35. Johnson & Johnson Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 36. UCB Pharma Corporate Summary
Table 37. UCB Pharma Epilepsy Diagnosis & Treatment Product Offerings
Table 38. UCB Pharma Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Corporate Summary
Table 40. Abbott Epilepsy Diagnosis & Treatment Product Offerings
Table 41. Abbott Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Epilepsy Diagnosis & Treatment Product Offerings
Table 44. GlaxoSmithKline Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Epilepsy Diagnosis & Treatment Product Offerings
Table 47. Novartis Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Epilepsy Diagnosis & Treatment Product Offerings
Table 50. Sanofi Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Takeda Corporate Summary
Table 52. Takeda Epilepsy Diagnosis & Treatment Product Offerings
Table 53. Takeda Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Medtronic Corporate Summary
Table 55. Medtronic Epilepsy Diagnosis & Treatment Product Offerings
Table 56. Medtronic Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Natus Medical Corporate Summary
Table 58. Natus Medical Epilepsy Diagnosis & Treatment Product Offerings
Table 59. Natus Medical Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Siemens Corporate Summary
Table 61. Siemens Epilepsy Diagnosis & Treatment Product Offerings
Table 62. Siemens Epilepsy Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Epilepsy Diagnosis & Treatment Segment by Type in 2021
Figure 2. Epilepsy Diagnosis & Treatment Segment by Application in 2021
Figure 3. Global Epilepsy Diagnosis & Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epilepsy Diagnosis & Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epilepsy Diagnosis & Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epilepsy Diagnosis & Treatment Revenue in 2021
Figure 8. By Type - Global Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 12. US Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 24. China Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epilepsy Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epilepsy Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. UCB Pharma Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Takeda Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Medtronic Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Natus Medical Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Siemens Epilepsy Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)